All stock lists
Avalo Therapeutics, Inc. (NASDAQ:AVTX)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
6.84-0.09 (-1.30%)
Insider Score
––Not scored
AVTX Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
AVTX analyst forecast
AVTX analyst consensus
Moderate Buy4 ratings
Buy 2 Hold 2 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
AVTX 12-month price target
$10.00+47.7% upsideaverage of 1 firm
$10.00High
$10.00Low
Best analysts covering AVTX
- BTIG100%success rate · 1 call
- HC Wainwright & Co.100%success rate · 1 call
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
AVTX analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Guggenheim | Neutral | — | — | Downgraded | 2026-10-23 |
| — | Wedbush | Outperform | — | — | Reiterated | 2026-10-23 |
| — | HC Wainwright & Co. | Neutral | — | — | Downgraded | 2026-10-23 |
| BTIG | Buy | $10.00 | +34.2% | Reiterated | 2026-10-23 | |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-08-07 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-08-07 |
| — | BTIG | Buy | — | — | Reiterated | 2026-06-16 |
| — | Wedbush | Outperform | — | — | Reiterated | 2026-05-14 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-05-14 |
| — | Mizuho | Outperform | — | — | Reiterated | 2026-05-14 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-05-14 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-05-11 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-05-06 |
| — | Wedbush | Outperform | — | — | Reiterated | 2026-05-06 |
| — | BTIG | Buy | — | — | Reiterated | 2026-05-06 |
| — | BTIG | Buy | — | — | Reiterated | 2026-04-13 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-03-25 |
| — | BTIG | Buy | — | — | Reiterated | 2026-03-24 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-01-15 |
| — | BTIG | Buy | — | — | Reiterated | 2025-09-29 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-09-17 |
| — | HC Wainwright & Co. | Neutral | — | — | Reiterated | 2025-03-20 |
| — | Oppenheimer | Outperform | — | — | Upgraded | 2024-04-16 |
| — | RBC Capital | Sector Perform | — | — | Downgraded | 2023-06-26 |
| — | Oppenheimer | Perform | — | — | Downgraded | 2023-06-26 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2023-05-09 |
| — | Jefferies | Underperform | — | — | Downgraded | 2023-02-07 |
| — | Jefferies | Hold | — | — | Downgraded | 2022-03-03 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2022-03-03 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2021-09-24 |
AVTX earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-23 | -1.54 | -0.74 | $0 | $80K |
| 2026-05-13 | -1.00 | -0.98 | $0 | $0 |
| 2026-08-06 | -0.58 | -0.83 | $0 | $0 |
| 2026-11-05 | -0.59 | 0.00 | $0 | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.